Las Vegas, NV -- (SBWIRE) -- 09/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Allied Nevada Gold Corp. (NYSEMKT: ANV s), Spirit Realty Capital Inc (NYSE:SRC), Catamaran Corp (USA)(NASDAQ:CTRX), ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS)
Allied Nevada Gold Corp. (NYSEMKT: ANV) managed to keep its fall at -1.51% on above-normal volume of 19.93M shares. The stock settled at $4.58 after floating in a range of $4.52 to $4.75. Its latest price has reached market capitalization of $476.05 million. Its 52-week range has been $3.54 to $41.02. Allied Nevada Gold Corp., a gold and silver producer, focuses on the mining, development, and exploration of properties in Nevada.
Has ANV Found The Bottom and Ready To Move Up? Find Out Here
Spirit Realty Capital Inc (NYSE:SRC) traded down on a volume of 13.38 million, higher than its standard daily volume. Shares have dropped-1.90% to $9.30. Over the last twelve months, the stock has lost-38.9% and faced a worst price of $8.24. Spirit Realty Capital, Inc is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing.
Has SRC Found The Bottom And Ready To Gain Momentum? Find Out Here
Catamaran Corp (USA) (NASDAQ:CTRX) settled -3.25% lower at $47.91 on above-normal volume of 3.17M shares during the last trading day. The stock has its 12-month high at $58.73 and 52-week low price was $45.43. It traded in a range of $47.23 to $49.36 during the last trading day. Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America.
Will CTRX Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) was up on high volume, trading at a volume of 3.63M versus its average daily volume of 1.53 million shares. At $38.48, the stock has attained market capitalization of 4.44 billion. Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.
Will ISIS Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)